A phase Ib study of combined VEGFR and mTOR inhibition with vatalanib and everolimus in patients with advanced renal cell carcinoma

A phase Ib study of combined VEGFR and mTOR inhibition with vatalanib and everolimus in patients with advanced renal cell carcinoma

Item
http://www.wikidata.org/entity/Q35135727
2D and 3D similarity landscape analysis identifies PARP as a novel off-target for the drug Vatalanib.A phase I dose-escalation study to assess safety, tolerability, pharmacokinetics, and preliminary efficacy of the dual mTORC1/mTORC2 kinase inhibitor CC-223 in patients with advanced solid tumors or multiple myeloma.Lenvatinib for use in combination with everolimus for the treatment of patients with advanced renal cell carcinoma following one prior anti-angiogenic therapy.Antiangiogenesis and vascular disrupting agents in cancer: circumventing resistance and augmenting their therapeutic utility.The effect of apatinib in the treatment of metastatic renal cell carcinoma: a case report and review of the literature.Hypertension Caused by Lenvatinib and Everolimus in the Treatment of Metastatic Renal Cell Carcinoma.Cancer stem cell markers predict a poor prognosis in renal cell carcinoma: a meta-analysis.Clinical development of mTor inhibitors for renal cancer.In Vitro Assays for Endothelial Cell Functions Required for Angiogenesis: Proliferation, Motility, Tubular Differentiation, and Matrix Proteolysis.
P2860

A phase Ib study of combined VEGFR and mTOR inhibition with vatalanib and everolimus in patients with advanced renal cell carcinoma

Item
http://www.wikidata.org/entity/Q35135727
description
2013 nî lūn-bûn
@nan
2013 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
A phase Ib study of combined V ...... advanced renal cell carcinoma
@ast
A phase Ib study of combined V ...... advanced renal cell carcinoma
@en
type
label
A phase Ib study of combined V ...... advanced renal cell carcinoma
@ast
A phase Ib study of combined V ...... advanced renal cell carcinoma
@en
prefLabel
A phase Ib study of combined V ...... advanced renal cell carcinoma
@ast
A phase Ib study of combined V ...... advanced renal cell carcinoma
@en
P1433
P1476
P2093
P2860
P304
P31
P356
P407
P433
P478
P50
P577
P698
P932
P356
P1433
P1476
A phase Ib study of combined V ...... advanced renal cell carcinoma
@en
P2093
P2860
P304
P31
P356
10.1016/J.CLGC.2013.11.020
P407
P433
P478
P50
P577
P698
P932